Related Experiment Video
Updated: Apr 4, 2026

Xenopus laevis as a Model to Identify Translation Impairment
Published on: September 27, 2015
Where are we going? Translational research in hepatic encephalopathy
Piero Amodio1, Sara Montagnese2, Kevin Mullen3
1Department of Medicine -DIMED, University of Padova, Via Giustiniani, 2, 35128, Padova, Italy. piero.amodio@unipd.it.
Translational medicine requires bidirectional communication between basic science and clinical practice. Research should focus on preventing hepatic encephalopathy (HE) and shortening its duration.
Area of Science:
- Translational medicine
- Medical research
- Clinical practice
Background:
- Translational medicine is a bidirectional process, not just applying basic science to clinics.
- Effective research interaction requires clear language and definitions across disciplines.
- Hepatic encephalopathy (HE) presents opportunities for research in prevention and treatment.
Purpose of the Study:
- To highlight the bidirectional nature of translational medicine.
- To identify key areas for research development in hepatic encephalopathy.
- To propose targets for basic and applied research in HE.
Main Methods:
- Conceptual analysis of translational medicine principles.
- Identification of research gaps in hepatic encephalopathy management.
- Literature review on HE prevention and treatment strategies.
Main Results:
- Translational medicine necessitates cross-fertilization between basic science, medical knowledge, and clinical application.
- Key areas for HE research include primary prevention, relapse prevention, and reducing episode duration.
- Investigating novel treatment combinations with potentially synergistic mechanisms is crucial.
Conclusions:
- Enhancing translational medicine requires fostering collaboration and clear communication.
- Targeted research in HE prevention and acute episode management is essential.
- Further studies comparing treatment strategies, including synergistic combinations, are warranted.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Leaky Scanning
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

